How to buy Lantern Pharma stock | $15.17

Lantern Pharma Inc is a biotechnology business based in the US. Lantern Pharma shares (LTRN) are listed on the NASDAQ and all prices are listed in US Dollars. Lantern Pharma employs 4 staff and has a market cap (total outstanding shares value) of USD$95.7 million.

How to buy shares in Lantern Pharma

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Lantern Pharma. Find the stock by name or ticker symbol: LTRN. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Lantern Pharma reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At last close price of USD$15.17, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Lantern Pharma, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Lantern Pharma. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Lantern Pharma share price

Use our graph to track the performance of LTRN stocks over time.

Lantern Pharma shares at a glance

• Key figures

Information last updated 2020-12-09.

Latest market close	USD$15.17
52-week range	USD$10.4 - USD$21.991
50-day moving average	USD$15.9173
200-day moving average	USD$15.2285
Wall St. target price	USD$27.33
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	USD$-0.4065

Buy Lantern Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy Lantern Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Lantern Pharma Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Lantern Pharma price performance over time

Historical closes compared with the close of $15.17 from 2020-12-09

1 week (2021-01-12)	-12.06%
1 month (2020-12-22)	-17.51%
3 months (2020-10-20)	-13.31%
6 months (2020-07-20)	22.39%

1 year (2020-01-18)	N/A
2 years (2019-01-18)	N/A
3 years (2018-01-18)	N/A
5 years (2016-01-18)	N/A

Lantern Pharma financials

Gross profit TTM	USD$0
Return on assets TTM	0%
Return on equity TTM	0%
Profit margin	0%
Book value	N/A
Market capitalisation	USD$95.7 million

TTM: trailing 12 months

Shorting Lantern Pharma shares

There are currently 36,397 Lantern Pharma shares held short by investors – that's known as Lantern Pharma's "short interest". This figure is 13.5% down from 42,082 last month.

There are a few different ways that this level of interest in shorting Lantern Pharma shares can be evaluated.

Lantern Pharma's "short interest ratio" (SIR)

Lantern Pharma's "short interest ratio" (SIR) is the quantity of Lantern Pharma shares currently shorted divided by the average quantity of Lantern Pharma shares traded daily (recently around 20798.285714286). Lantern Pharma's SIR currently stands at 1.75. In other words for every 100,000 Lantern Pharma shares traded daily on the market, roughly 1750 shares are currently held short.

However Lantern Pharma's short interest can also be evaluated against the total number of Lantern Pharma shares, or, against the total number of tradable Lantern Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lantern Pharma's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Lantern Pharma shares in existence, roughly 10 shares are currently held short) or 0.0158% of the tradable shares (for every 100,000 tradable Lantern Pharma shares, roughly 16 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lantern Pharma.

Find out more about how you can short Lantern Pharma stock.

Lantern Pharma share dividends

We're not expecting Lantern Pharma to pay a dividend over the next 12 months.

Lantern Pharma overview

Lantern Pharma Inc., a clinical stage oncology biotechnology company, focuses on the development of precision oncology therapeutics using artificial intelligence, genomics, and machine learning. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, prostate cancer. The company also develops LP-300 as a combination therapy for female non or never-smokers with non-small cell lung cancer adenocarcinoma. In addition, its preclinical development drug candidate is LP-184, an alkylating agent that damages DNA in cancer cells that overexpress certain biomarkers and is from the fulvene class of compounds. The company was incorporated in 2013 and is based in Dallas, Texas.

Frequently asked questions

• What percentage of Lantern Pharma is owned by insiders or institutions?

  Currently 27.143% of Lantern Pharma shares are held by insiders and 31.115% by institutions.

• How many people work for Lantern Pharma?

  Latest data suggests 4 work at Lantern Pharma.

• When does the fiscal year end for Lantern Pharma?

  Lantern Pharma's fiscal year ends in December.

• Where is Lantern Pharma based?

  Lantern Pharma's address is: 1920 McKinney Avenue, Dallas, TX, United States, 75201

• What is Lantern Pharma's ISIN number?

  Lantern Pharma's international securities identification number is: US51654W1018